SCHEMBL9796248

SCHEMBL9796248

NS(=O)(=O)c1nnnn1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.61
MAPT P10636 8/20 0.61
PTGS2 P35354 4/20 0.56
NPSR1 Q6W5P4 5/20 0.55
LMNA P02545 3/20 0.55
TP53 P04637 3/20 0.55
HPGD P15428 3/20 0.55
HTT P42858 3/20 0.55
HSD17B10 Q99714 3/20 0.55
CCR6 P51684 1/20 0.47
CACNA1B Q00975 1/20 0.47
APBA1 Q02410 1/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
TSHR P16473 1/20 0.46
GAA P10253 1/20 0.46
S1PR4 O95977 1/20 0.45
S1PR1 P21453 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16162343 0.85 ALDH1A1 (0.65) ALDH1A1MAPTPTGS2NPSR1LMNA
SCHEMBL12443641 0.81 MAPT (0.69) ALDH1A1MAPTPTGS2NPSR1LMNA
SCHEMBL9615741 0.81 ALDH1A1 (0.61) ALDH1A1MAPTPTGS2NPSR1LMNA
SCHEMBL27940169 0.81 ALDH1A1 (0.61) ALDH1A1MAPTPTGS2NPSR1LMNA
SCHEMBL2978401 0.79 ALDH1A1 (0.71) ALDH1A1MAPTPTGS2NPSR1LMNA
SCHEMBL14194286 0.79 ALDH1A1 (0.58) ALDH1A1MAPTPTGS2NPSR1LMNA
SCHEMBL13344784 0.77 ALDH1A1 (0.56) ALDH1A1MAPTPTGS2NPSR1LMNA
SCHEMBL31642640 0.77 ALDH1A1 (0.69) ALDH1A1MAPTNPSR1LMNATP53
SCHEMBL8177086 0.76 ALDH1A1 (1.00) ALDH1A1MAPTNPSR1LMNATP53
SCHEMBL3165110 0.75 ALDH1A1 (0.66) ALDH1A1MAPTNPSR1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990523-A Treatment of chronic inflammatory joint disease with arylsulfonamides A. H. ROBINS COMPANY, INCORPORATED (US) 1991-02-05 US disclosed
WO-1990015600-A2 TREATMENT OF CHRONIC INFLAMMATORY JOINT DISEASE WITH ARYLSULFONAMIDES A.H. ROBINS COMPANY, INCORPORATED (US) 1990-12-27 WO disclosed